As previous studies have shown trypsin to play a role in tumorigenesis and cancer progression [25], its increased levels may support the hypothesis that trypsin has a tumorigenic role in OC, which can be mediated by PAR2 (protease activated receptor 2) receptor and further potentiated by HE4 [26,27,28]. Here, F2RL1 is linked to cancer.